Depressive disorder, major

This phase 3 trial is testing whether lumateperone (Caplyta), taken alone, can reduce symptoms of major depressive disorder (MDD) compared to a placebo. About 585 adults with MDD will receive one of two doses of lumateperone or a placebo for six weeks, followed by a long-term ext…

This phase 3 trial tests whether adding an experimental drug called brenipatide to standard depression treatment can delay the return of major depressive symptoms in adults with major depressive disorder. Participants receive either brenipatide or a placebo by injection, alongsid…

This study tests whether a non-invasive brain stimulation technique called rTMS can improve cognitive flexibility—the ability to adapt thinking—in people with major depression. 105 participants will receive either active stimulation to two brain areas, active stimulation to one a…

This study aims to see if acupuncture is more effective than a placebo for treating major depression. Researchers will compare acupuncture to the antidepressant escitalopram in 216 adults who are not currently taking any depression medication. The goal is to find out if this anci…

This study will test a mobile app designed to help veterans who have both PTSD and depression. The app teaches skills to manage emotions and relationships, based on a proven talk therapy. Forty veterans will use the app and answer surveys to see if it improves their daily functio…

This study will follow 45,000 university students over three years to understand how financial struggles, housing issues, and loneliness affect their mental health and whether they seek help. Participants will fill out questionnaires about their well-being and life circumstances.…